Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

The private for-profit sector is an important source of treatment for malaria. However, private patients face high prices for the recommended treatment for uncomplicated malaria, artemisinin combination therapies (ACTs), which makes them more likely to receive cheaper, less effective non-artemisinin...

Descripción completa

Detalles Bibliográficos
Autores principales: Palafox, Benjamin, Patouillard, Edith, Tougher, Sarah, Goodman, Catherine, Hanson, Kara, Kleinschmidt, Immo, Torres Rueda, Sergio, Kiefer, Sabine, O’Connell, Kate, Zinsou, Cyprien, Phok, Sochea, Akulayi, Louis, Arogundade, Ekundayo, Buyungo, Peter, Mpasela, Felton, Poyer, Stephen, Chavasse, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://www.ncbi.nlm.nih.gov/pubmed/25944705
http://dx.doi.org/10.1093/heapol/czv031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://www.ncbi.nlm.nih.gov/pubmed/25944705
http://dx.doi.org/10.1093/heapol/czv031

Ejemplares similares